(Q33634304)

28 July 2017

1 reference

title

Challenges in the development of antimalarial drugs with causal prophylactic activity (English)

1 reference

28 July 2017

0 references

Chulay JD

1

1 reference

28 July 2017

publication date

1 November 1998

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

28 July 2017

published in

1 reference

28 July 2017

volume

92

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

577-579

1 reference

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Paludrine in prophylaxis and treatment of malarial infections caused by a West African strain of P. falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Atovaquone and proguanil for the treatment of malaria in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Effect of certain drugs on exoerythrocytic parasites of Plasmodium cynomolgi.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Chemotherpeutic suppression and prophylaxis in Malaria. An experimental investigation undertaken by medical research teams in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Researches on paludrine (M.4888) in malaria; an experimental investigation undertaken by the L.H.Q. Medical Research Unit (A.I.F.) Cairns, Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Discovery of the hypnozoite and a new theory of malarial relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Atovaquone and proguanil for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2990772-6

7 January 2021

10.1016/S0035-9203(98)90772-6

Identifiers

DOI

1 reference

28 July 2017

1 reference